mRNA-1273 COVID-19 Vaccination in Patients Receiving Chemotherapy, Immunotherapy, or Chemoimmunotherapy for Solid Tumours
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Lancet Oncol 2021 Dec 01;22(12)1681-1691, SF Oosting, AAM van der Veldt, CH GeurtsvanKessel, RSN Fehrmann, RS van Binnendijk, AC Dingemans, EF Smit, TJN Hiltermann, G den Hartog, M Jalving, TT Westphal, A Bhattacharya, M van der Heiden, GF Rimmelzwaan, P Kvistborg, CU Blank, MPG Koopmans, ALW Huckriede, CACM van Els, NY Rots, D van Baarle, JBAG Haanen, EGE de VriesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.